Synageva BioPharma Corp. (NASDAQ: GEVA)

Synageva is a biopharmaceutical company dedicated to discovering, developing and delivering medicines for patients with rare diseases and high unmet medical needs. We are passionate about our commitment to improving the lives of patients for generations to come. Our experienced team has developed and delivered several life-saving therapies to patients whose diseases were once considered too rare for developing treatments. We believe that every patient deserves treatment options, no matter how rare their disease.

NASDAQ: GEVA
$ 98.73 -0.69 (0.69%)
Day High: 103.30
Day Low:  96.08
Volume:    319,500
4:00 PM ET on
Feb 27, 2015

Delayed ~20 min., by eSignal.

Recent Press Releases

Events & Presentations